Crossbow Therapeutics vs Moderna
Crossbow Therapeutics vs Moderna, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crossbow Therapeutics is on 55/100 and Moderna on 77/100.
Where each one leads
Crossbow Therapeutics
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 55/100
- domain rating: 79/100 against 25/100
- headcount: 6,297 against 40
- funding raised: $4.5B against $157M
At a glance
| Measure | Crossbow Therapeutics | Moderna |
|---|---|---|
| What it is | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2021 | 2010 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Crossbow Therapeutics | Moderna |
|---|---|---|
| Employees | 40 | 6,297 |
| Open roles | Not published | 100 |
| Total funding | $157M | $4.5B |
| Latest round | Series B | Funding Round |
| LinkedIn followers | Not published | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crossbow Therapeutics | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 77/100 |
| Traction | 56/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 15/100 | 46/100 |
| Quality | 65/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crossbow Therapeutics | Moderna |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| CMS | Wix | Not detected |
| Frameworks | Not detected | Next.js |
| Open source | Yes | No |
What users say
| Measure | Crossbow Therapeutics | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
Crossbow Therapeutics vs Moderna: common questions
Which is better, Crossbow Therapeutics or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Crossbow Therapeutics and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 55/100), domain rating (79/100 against 25/100), headcount (6,297 against 40), funding raised ($4.5B against $157M).
Read the full Crossbow Therapeutics review and pricing or the Moderna review and pricing. You can also browse other Crossbow Therapeutics alternatives we track.